The expression of JOSD1 was aberrant in HNSCC specimens, and its depletion improved cisplastin-induced apoptosis of HNSCC cells, suppressed tumour growth and improved chemosensitivity in vitro via regulation by the epigenetic regulator, BRD4 [22]. The gene discussed is BRD4; the disease is head and neck squamous cell carcinoma.